Neurology Group of Bergen County, P.A. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01146002
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

guanfacine (tenex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Hyperkinesis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1